Mexico Clinical Laboratory Tests Market Size & Outlook
Mexico clinical laboratory tests market, 2018-2030 (US$M)
Related Markets
Mexico clinical laboratory tests market highlights
- The Mexico clinical laboratory tests market generated a revenue of USD 1,857.5 million in 2023 and is expected to reach USD 3,707.1 million by 2030.
- The Mexico market is expected to grow at a CAGR of 10.4% from 2024 to 2030.
- In terms of segment, hba1c tests was the largest revenue generating type in 2023.
- HGB/HCT tests is the most lucrative type segment registering the fastest growth during the forecast period.
Clinical laboratory tests market data book summary
| Market revenue in 2023 | USD 1,857.5 million |
| Market revenue in 2030 | USD 3,707.1 million |
| Growth rate | 10.4% (CAGR from 2023 to 2030) |
| Largest segment | Hba1c tests |
| Fastest growing segment | HGB/HCT tests |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Complete blood count, HGB/HCT tests, Basic metabolic panel, BUN creatinine tests, Electrolytes testing, HbA1c tests, Comprehensive metabolic panel tests, Liver panel tests, Renal panel tests, Lipid panel tests |
| Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Labcorp Holdings Inc, ARUP Laboratories, OPKO Health Inc, Clinical Reference Laboratory, Sonic Healthcare Ltd, Cinven, Unilabs |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.6% of the global clinical laboratory tests market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil clinical laboratory tests market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 4,855.1 million by 2030.
Hba1c tests was the largest segment with a revenue share of 12.31% in 2023. Horizon Databook has segmented the Mexico clinical laboratory tests market based on complete blood count, hgb/hct tests, basic metabolic panel, bun creatinine tests, electrolytes testing, hba1c tests, comprehensive metabolic panel tests, liver panel tests, renal panel tests, lipid panel tests covering the revenue growth of each sub-segment from 2018 to 2030.
High blood pressure and cardiovascular diseases are major causes of death and disability worldwide. Mexico is at an advanced stage in the epidemiologic transition with the burden of disease at the national level dominated by noncommunicable diseases and related risk factors, including very high rates of heart disease & hypertension.
Cardiovascular disease and stroke are the second and third leading causes of death in Mexico. Around 31.7% of the population in Mexico aged 50 and above had systolic hypertension. The Mexican government is trying to develop new policies to improve people’s health.
These include expanding public healthcare institutions’ coverage along with standardizing the services offered by all of them. The government is also implementing new programs for preventing obesity, diabetes, and chronic diseases, such as renal failure & other kidney diseases.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Laboratory Tests Market Scope
Clinical Laboratory Tests Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico clinical laboratory tests market size, by type, 2018-2030 (US$M)
Mexico Clinical Laboratory Tests Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
